| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83dffc287358331deccd774ddf93f551 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34 |
| filingDate |
2020-01-29^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-04-02^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9a2f1f91c9e5dd98ed41835b6283d69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8da2992dc2790598a6d23872867aa4ee |
| publicationDate |
2021-04-02^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102235846-B1 |
| titleOfInvention |
Novel application of catechol group grafted polymeric composition |
| abstract |
The present invention relates to a new use of a polymer composition grafted through the introduction of a catechol functional group, The composition for sustained-release coating provided in one aspect of the present invention is formulated with a drug, so that not only can excellently induce long-term sustained release of the drug even in the body organs having neutral or weakly basic properties, but also significantly increase the carrying capacity of the drug. Since it can be improved, it can be very usefully applied to the design of an oral sustained-release formulation or a drug-release control coating of a medical device such as a drug-release stent. |
| priorityDate |
2020-01-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |